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Assessment of Lymph Node Metastases
by Contrast-Enhanced MR Imaging in a
Head and Neck Cancer Model 
Objective: We wanted to investigate the accuracy of contrast-enhanced MR
imaging for the detection of lymph node metastases in a head and neck cancer
rabbit model.
Materials and Methods: The metastatic lymph node model we used was cre-
ated by inoculating VX2 tumors into the auricles of six New Zealand White rab-
bits. T1-weighted MR images were obtained before and after injecting gadopen-
tetate dimeglumine at three weeks after tumor cell inoculation. The sizes, signal
intensity ratios (i.e., the postcontrast signal intensities of the affected nodes rela-
tive to the adjacent muscle) and the enhancement patterns of 36 regional lymph
nodes (parotid and caudal mandibular nodes) were evaluated on MR images and
then compared with the histopathologic findings.
Results: No statistical difference was found between the sizes of 12 metastatic
(10.5 3.2 mm) and 24 hyperplastic (8.0 3.6 mm) lymph nodes (p > 0.05). On
the contrast-enhanced T1-weighted MR images, nine metastatic and four hyper-
plastic lymph nodes had peripheral high and central low signal intensity, whereas
three metastatic and 20 hyperplastic lymph nodes had homogeneous high signal
intensity. Using a signal intensity ratio less than one as a diagnostic criterion for a
metastatic lymph node, the sensitivity, specificity and positive and negative pre-
dictive values of the enhanced MR images were 75% (9/12), 83% (20/24), 69%
(9/13) and 87% (20/23), respectively, with areas under receiver-operating-char-
acteristic curve values of 0.81.
Conclusion: This experimental study confirms that metastatic and hyperplastic
lymph nodes can be differentiated using MR images on the basis of the contrast
uptake patterns, but that they cannot be differentiated using any particular size
criteria.
he detection of metastasis to lymph nodes is critical for the tumor staging
and preoperative planning in patients with head and neck cancer (1 3).
Contrast material enhanced computed tomography (CT) and conven-
tional magnetic resonance (MR) imaging are limited in terms of their abilities to detect
metastatic disease in the normally sized lymph nodes because the diagnostic criteria
that are used are based on lymph node size and shape (4 6). However, the use of
contrast agent can improve both the sensitivity and specificity of nodal evaluation by
MR imaging because the identification of necrosis is a reliable sign of a metastatic node
(7 11).
The development of an adequate animal model would be quite useful to compare
the accuracies of different imaging modalities or different contrast agents with respect
to nodal evaluation. The VX2 tumor inoculated into the auricles shows rapid growth,
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Tand lymph node metastases are almost always observed in
the parotid gland within 21 days of subcutaneous implanta-
tion (12). This metastatic model has been used to study the
sentinel node concept and to evaluate the effects of antitu-
mor agent in the context of human head and neck
squamous cell carcinoma (12, 13). But to the best of our
knowledge, this head and neck carcinoma model has not
been used for contrast-enhanced MR imaging.
The purpose of this study was to investigate the accuracy
of contrast-enhanced MR imaging for the detection of
lymph node metastases in a head and neck cancer rabbit
model.
MATERIALS AND METHODS
Animals and the Experimental Design
All the studies were conducted with the approval of the
animal care committee at Seoul National University
Hospital. The experiments were performed using six New
Zealand White rabbits (Central Biological Laboratory,
Seoul, Korea) weighing 2.5 3.0 kg each. The animals
were allowed food and water ad libitum between the
various procedures. They were anesthetized by an
intramuscular injection of 50 mg/kg of ketamine
hydrochloride (Ketalar , Yuhan Yanghang, Seoul, Korea)
and 20 mg/kg xylazine hydrochloride (Rompun Bayer
Korea, Seoul, Korea). 
To induce head and neck cancer, 0.5 ml of a cell suspen-
sion of VX2 carcinoma was inoculated subcutaneously into
the cranial section of the lower third of both auricles. The
experimental auricular VX2 rabbit carcinoma was
prepared in a manner described previously (12). The MR
imaging was performed approximately three weeks after
VX2 inoculation. Solid auricular masses were palpable in
all animals.
MR Imaging
The anesthetic regimen used for tumor implantation was
also used for MR imaging. The ear vein of a rabbit was
cannulated with a 22-gauge infusion set that was connected
to a 1 mL syringe loaded with contrast agent. All the
animals were imaged in the prone position. All examina-
tions were performed using a 1.5-T superconducting
magnet (Signa Horizon, GE Medical Systems, Milwaukee,
WI) and with employing a standard transmit-receive
quadrature head coil. After obtaining the routine localiza-
tion images, the T1-weighted spin-echo (SE) sequence was
performed in the coronal plane with using the following
parameters: a TR of 400 ms, a TE of 12 ms and two excita-
tions. The slice thickness used was 2 mm without a gap, the
matrix number was 256 160 and the field of view (FOV)
was 16 cm. The T2-weighted fast SE sequence (TR/TE:
3500/84 ms, 2 excitations) was also obtained. The coronal
three-dimensional fast spoiled gradient-recalled echo (3D-
SPGR) T1-weighted images (TR/TE, 19.7/1.8 ms; FOV, 20
20 cm) were obtained before and 2 minutes after 0.1
mmol/kg of body weight gadopentetate dimeglumine
(Magnevist Schering, Germany) had been administered
by manual injection via an ear vein.
Image Analysis
All MR images were assessed with an emphasis placed on
the parotid and caudal mandibular lymph nodes. The
images were retrospectively evaluated by consensus
between two experienced radiologists (who unaware of the
study details) for the lymph node size, the signal intensity
ratios and the enhancement pattern. No attention was paid
to the stage of the auricle carcinoma. The locations of the
suspicious lymph nodes were designated as parotid or
mandibular. All lymph nodes on the right or left side were
interpreted and the results were compared with the
pathological findings. 
The craniocaudal longitudinal diameters of the lymph
nodes (maximum diameter) were measured on the selected
T1-weighted and T2-weighted MR images. On the contrast-
enhanced T1-weighted MR images, circular regions of
interest (1.0 2.0 mm in diameter) were positioned on the
hypointense area to determine signal intensities of the
lymph nodes by consensus between the two radiologists.
The signal intensity ratio was defined as the postcontrast
signal intensity of an affected node relative to the adjacent
muscle, and this was calculated for the metastatic and
hyperplastic lymph nodes. 
Histopathologic Analysis
After the MR images were obtained, the animals were
sacrificed by administering a lethal dose (90 mg/kg) of
intravenous sodium pentobarbital (Pentothal , Choong
Wae Pharmacy, Seoul, Korea). The parotid and mandibu-
lar lymph nodes were exposed to determine their positions
and then they were carefully removed. The pathologic
specimens were fixed in 10% phosphate-buffered
formaldehyde for subsequent embedding in paraffin and
the pathologic analysis. The histologic sections were
obtained in planes paralleling the MR imaging orientations.
Serial sections of the entire lymph nodes were obtained
and subjected to hematoxylin-eosin (HE) staining, which
was used to assess the lymph node morphology.
Two observers simultaneously reviewed all the slides
with using a double-headed light microscope. The total
number of nodes, the number of metastatic and hyperplas-
tic lymph nodes, the number of necrotic metastatic nodes
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documented. Discrepant interpretations were resolved by
consensus.
Statistical Analysis 
The mean sizes of metastatic and hyperplastic lymph
nodes were compared by using the independent t-test in
the SigmaStat 2.0 and SAS program for Windows version
11.0 (SPSS Science, Chicago, and the SAS Institute, Cary,
NC). We investigated the use of node size and the signal
intensity ratio as the criteria for the differentiation of
metastatic and hyperplastic lymph nodes, and for calculat-
ing the accuracies, sensitivities, specificities and the
positive and negative predictive values. Receiver operating
characteristic (ROC) curve analyses were also performed
by calculating the areas under the appropriate ROC curves
(Az) (14). Binormal ROC curves were fitted using ROCKIT
0.9 software (15). 
RESULTS
Histopathologic analyses of the 36 lymph nodes in six
rabbits revealed 12 metastatic lymph nodes and 24
hyperplastic lymph nodes (Figs. 1, 2). For all the rabbits,
lymphogenic metastasis was observed in the first draining
parotid lymph node, except in one rabbit that showed
lymphogenic metastasis in the caudal mandibular lymph
node. Focal necrosis was identified in all the metastatic
lymph nodes.
MR Imaging Findings
The size distributions of all the lymph nodes and the
relations between the size measurements and the signal
intensity ratios are shown in Figure 3. The average
maximum diameters of the metastatic and hyperplastic
lymph nodes were 10.5 3.2 mm and 8.0 3.6 mm,
respectively, which was not statistically significant (p >
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Fig. 1. The coronal T1- (A) and T2-
weighted (B) MR images obtained
before injecting gadopentetate dimeglu-
mine show enlarged parotid lymph
nodes (arrow). The coronal T1-weighted
MR images obtained before (C) and
after (D) injecting gadopentetate
dimeglumine 3 weeks after tumor cell
inoculation show enlarged parotid lymph
nodes (arrow) with rim enhancement.
The photomicrograph (E) shows a
metastatic parotid lymph node with
central necrosis (H & E stain; original
magnification,  2). 
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Fig. 3. A. Graph showing the size distribution of the metastatic and hyperplastic lymph nodes in rabbits. The metastatic lymph nodes were
larger (10.5 3.2 mm) than the hyperplastic nodes (8.0 3.6 mm), however, the difference was not statistically significant (p > 0.05).
B. Graph showing the signal intensity ratio of the metastatic and hyperplastic lymph nodes in rabbits with respect to the node size. The
signal intensity ratio of the metastatic lymph nodes (0.82 0.16) was significantly lower than that of the hyperplastic lymph nodes (2.02
0.86) (p < 0.05). The size of the diseased lymph node and the signal intensity ratio was not found to be correlated (p > 0.05).
Fig. 2. The coronal T1- (A) and T2-
weighted (B) MR images obtained
before injecting gadopentetate dimeglu-
mine show enlarged parotid lymph
nodes (arrow). The coronal T1-weighted
MR images obtained before (C) and
after (D) injecting gadopentetate
dimeglumine at three weeks after tumor
cell inoculation show enlarged parotid
lymph nodes (arrow) with homogenous
enhancement. The photomicrograph (E)
shows a hyperplastic parotid lymph node
(H & E stain; original magnification,  2). 
ABC
DE0.05). The mean signal intensity ratios of the metastatic
and hyperplastic lymph nodes were 0.82 0.16 and 2.02
0.86, respectively, which was statistically significant (p <
0.05). The correlation coefficient between the node size
and signal intensity was 0.06, which was not statistically
significant (p > 0.05)
The contrast-enhanced T1-weighted MR images showed
peripheral high and central low signal intensity (n = 13) or
homogenous high signal intensity (n = 23) (Figs. 1, 2). Of
the 13 lymph nodes with peripheral high and central low
signal intensity, nine nodes were confirmed to be metasta-
tic (Fig. 1) and were four hyperplastic (Fig. 2) by
microscopic examination. Of the 23 nodes with homoge-
nous high signal intensity, three nodes were metastatic and
20 nodes were hyperplastic.
Diagnostic Accuracy
Using a cutoff value of a maximal diameter of 10 mm in
the coronal plane, the sensitivity and specificity were 58%
(7/12) and 79% (19/24), respectively, and they were 83%
(10/12) and 50% (12/24), respectively, at a cutoff value of
7 mm. Using a signal intensity ratio less than one as a
diagnostic criterion for a metastatic lymph node, the MR
imaging had an accuracy of 81% (29/36), a sensitivity of
75% (9/12), a specificity of 83% (20/24), a positive predic-
tive value of 69% (9/13) and a negative predictive value of
87% (20/23) for the detection of lymph node metastasis.
By ROC analysis, the Az value with a 95% confidence
interval (CI) for a signal intensity ratio less than 1 on the
contrast-enhanced T1-weighted MR images was 0.81 (95%
CI: 0.63, 0.92), whereas that for a size measurement
criterion of 10 mm was 0.72 (95% CI: 0.54, 0.86) (Fig. 4).
The difference was significantly significant (p < 0.05). 
DISCUSSION
The status of the cervical lymph nodes is one of the most
important factors influencing the therapeutic management
and outcome for patients suffering with head and neck
squamous cell carcinoma. CT and MR imaging provide
additional information regarding nodes that are inaccessi-
ble to palpation and the modalities may also show nodal
necrosis, which is equated with tumor involvement in the
appropriate clinical setting (16). These modalities can
detect metastatic nodes in 38% to 67% of patients with no
obvious nodal disease as revealed by clinical palpation
(17). A tradeoff between sensitivity and specificity is
necessary when only nodal size is considered. In our study,
the sensitivity and specificity of MR imaging were 58%
(7/12) and 79% (19/24), respectively, at a cutoff value of
10 mm, and they were 83% (10/12) and 50% (12/24),
respectively, at a cutoff value of 7 mm. 
Our experimental results show that the signal intensity
ratios of lymph nodes according to MR imaging provide
more useful information than the size criteria for the
detection of regional metastatic lymph nodes in this head
and neck carcinoma model. In our study, the 3D high-
resolution MR images were obtained before and after
injection of a conventional extracellular agent, i.e.,
gadopentetate dimeglumine. Nine (75%) of 12 metastatic
cases showed peripheral high and central low signal
intensity on the contrast-enhanced T1 weighted MR
images. This enhancement pattern was histologically
related to nodal necrosis. Dynamic contrast-enhanced MR
imaging and the signal intensity curve analysis have
recently been applied to the cervical lymph nodes in 21
patients with squamous cell carcinoma in the head and
neck (18). A significantly longer time to peak, a lower
peak enhancement, a lower maximum slope and a slower
washout slope were found in tumor-involved lymph nodes
compared with normal lymph nodes. The authors
concluded that in the malignant lymph node there is a
decreased transfer of contrast material to the tissue and a
reduced volume of extracellular space (18). 
New MR lymphotropic magnetic nanoparticles (19) and
macrocyclic gadolinium chelates (8 10) have recently
been shown to significantly improve the MR imaging
diagnostic accuracy for nodal staging in animals and
humans. Positron emission tomography (PET) using 18F-
fluorodeoxyglucose (FDG) or integrated PET/CT is known
to be a sensitive tool for the detection of hypermetabolic
malignant lymph nodes (20). The described VX2 tumor
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Fig. 4.  Graph showing the receiver operating characteristic
curves of size and signal intensity ratio for the detection of
metastatic lymph nodes. The Az values were 0.81 for the signal
intensity ratio and 0.72 for size as determined from the MR
images, which were significantly different (p < 0.05). CI =
confidence intervalmodel in the rabbit could be used to compare the accura-
cies of using different imaging modalities or different
contrast agents for nodal evaluations because as the
present study shows, size criteria alone could not differen-
tiate metastatic and hyperplastic regional lymph nodes in
this model (21, 22). In the present study, tumor metastases
to the parotid and/or mandibular lymph nodes developed
in all the rabbits three weeks after auricular VX2
carcinoma inoculation. However, the limitations associated
with the small number of animals examined during this
study should be considered.
In conclusion, this experimental study confirms that
metastatic and hyperplastic lymph nodes can be differenti-
ated with using MR images and based on the contrast
uptake patterns, but not based on any size criteria. This
auricular VX2 carcinoma model could be used to compare
the accuracies of the different imaging modalities or the
different contrast agents for conducting lymph node
evaluations. 
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